Valuation: BioNTech SE

Market Cap 2.03TCr 2.3TCr 1.89TCr 1.73TCr 3.25TCr 2,20900Cr 3.29TCr 22TCr 8.75TCr 1,09100Cr 8.65TCr 8.46TCr 3,77000Cr P/E 2026 *
-18.2x
P/E 2027 * -17.5x
Enterprise Value 939.58Cr 1.07TCr 874.63Cr 803.24Cr 1.51TCr 1,02500Cr 1.53TCr 10TCr 4.06TCr 51TCr 4.01TCr 3.93TCr 1,74900Cr EV / Sales 2026 *
4.33x
EV / Sales 2027 * 4.92x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+1.22%
1 week-0.38%
Current month-1.15%
1 month-2.42%
3 months-9.88%
6 months-20.82%
Current year-3.38%
1 week 88.5
Extreme 88.5
93.15
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
12/05/26 Free

General Counsel

22,655 0.0094%
12/05/26 Free

Executive/Senior Manager

22,655 0.0094%
12/05/26 Free

Chief Operating Officer

22,655 0.0094%
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%-0.38%-18.45%-14.37% 2.3TCr
-2.25%+1.55%+50.84%+70.04% 5.62TCr
-1.32%-0.97%+38.41%+77.52% 5.48TCr
+0.17%-3.47%+3.05%+391.12% 2.27TCr
-0.21%+0.84%+22.48%-7.92% 2.02TCr
0.00%+3.00%+27.41%-29.52% 1.78TCr
-0.97%+0.89%+37.28%+539.62% 1.57TCr
-6.69%-5.11%+166.00%+304.89% 1.52TCr
-0.02%-0.37%+25.95%+181.66% 1.4TCr
-2.27%-1.25%+83.56%+162.74% 1.27TCr
Average -1.26%-0.18%+43.65%+167.58% 2.52TCr
Weighted average by Cap. -1.27%+0.31%+39.97%+133.72%

Financials

2026 *2027 *
Net sales 216.8Cr 246.61Cr 201.81Cr 185.34Cr 348.02Cr 24TCr 352.61Cr 2.4TCr 936.88Cr 12TCr 925.76Cr 905.81Cr 40TCr 223.08Cr 253.76Cr 207.66Cr 190.71Cr 358.1Cr 24TCr 362.82Cr 2.47TCr 964.02Cr 12TCr 952.58Cr 932.05Cr 42TCr
Net income -104.22Cr -118.55Cr -97Cr -89Cr -167.3Cr -11TCr -169.5Cr -1.15TCr -450.37Cr -5.61TCr -445.02Cr -435.43Cr -19TCr -116.46Cr -132.48Cr -108.41Cr -100Cr -186.96Cr -13TCr -189.42Cr -1.29TCr -503.29Cr -6.27TCr -497.32Cr -486.6Cr -22TCr
Net Debt -1.09TCr -1.23TCr -1.01TCr -927.93Cr -1.74TCr -1,18400Cr -1.77TCr -12TCr -4.69TCr -58TCr -4.64TCr -4.54TCr -2,02100Cr -928.56Cr -1.06TCr -864.37Cr -793.82Cr -1.49TCr -1,01300Cr -1.51TCr -10TCr -4.01TCr -50TCr -3.97TCr -3.88TCr -1,72900Cr
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
28/26/28 $92.21 +1.23% 3,56,420
27/26/27 $91.09 +1.97% 6,87,342
24/26/24 $89.33 -2.97% 8,86,104
23/26/23 $92.06 +0.25% 5,39,216
22/26/22 $91.83 -0.54% 5,08,360
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
80.08EUR
Average target price
106.88EUR
Spread / Average Target
+33.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock